Latham & Watkins
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Latham & Watkins’ healthcare and life sciences team demonstrates wide-ranging expertise, encompassing private equity, M&A and regulatory compliance matters, as well as antitrust and data protection litigation. Leading the team, Eveline Van Keymeulen is well regarded for the depth of her expertise in key strategic legal and policy developments relating to the EU regulatory framework. Olivier du Mottay showcases strong credentials in M&A matters, in particular international private equity transactions and leveraged acquisitions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Eveline Van Keymeulen stands out as one of Europe's leading experts in life sciences regulations, with comprehensive coverage ranging from clinical trials to market access and post-marketing obligations.'
- ‘Latham's healthcare and life sciences team, led by Eveline Van Keymeulen, distinguishes itself through its comprehensive coverage of the product lifecycle – from clinical trials to post-market obligations – and its seamless management of pan-European cases.'
Key clients
- Coatue Management Goldman Sachs Asset Management TA Associates Abbott AbbVie Argenx Astorg Bain Capital Balt Bridgepoint Centessa Direct Relief Foundation EFPIA ESMO Eurazeo Galderma GRAIL Ipsen Kenvue L’Oréal Marinus Pharmaceuticals MeiraGTX Norgine Norgine ReCor Medical Samsung Medison Soterios Swedish Orphan Biovitrum AB (SOBI) Tempus Labs, Inc. Veracyte Verdiva Whoop Xylocor Zo
Work highlights
Advising EFPIA on a variety of cutting-edge legal and policy issues that are shaping the EU regulatory pharmaceutical framework.